(NASDAQ: ADPT) Adaptive Biotechnologies's forecast annual revenue growth rate of 16.23% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 235.31%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Adaptive Biotechnologies's revenue in 2025 is $205,216,000.On average, 5 Wall Street analysts forecast ADPT's revenue for 2025 to be $35,693,310,224, with the lowest ADPT revenue forecast at $34,124,584,352, and the highest ADPT revenue forecast at $38,997,349,632. On average, 5 Wall Street analysts forecast ADPT's revenue for 2026 to be $41,104,820,615, with the lowest ADPT revenue forecast at $38,449,163,538, and the highest ADPT revenue forecast at $42,575,786,634.
In 2027, ADPT is forecast to generate $50,213,541,663 in revenue, with the lowest revenue forecast at $48,712,425,409 and the highest revenue forecast at $51,760,340,091.